This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Multiple Sclerosis: Research Progress, Clinical Advances
Cognitive Decline in MS Linked to Multiple Cortical Regions
In older patients with multiple sclerosis (MS), cognitive impairment is associated with global and thalamic changes, as well as with thickness of multiple cortical areas, according to the results of a recent study.
Multiple Sclerosis: The Role of Genetic Variation in Progression
Genetic loci that are associated with disability in multiple sclerosis have been identified as contributing to its progression, showing that the central nervous system, not the immune system, determines outcome.
MS Disease-Modifying Therapies: How Prescribing Patterns have Changed
Oral disease-modifying therapies are now the most commonly used initiation therapy for multiple sclerosis. Balancing efficacy and ease of administration with cost and insurance limitations should be part of the decision-making process.